Are Lawmakers Serious About Drug Costs?

The potential legislative package would draw from a slate of bills recently passed by House Ways and Means and House Energy and Commerce, the two top committees with health-care jurisdiction. These bills include measures requiring more transparency from drug middlemen and drug makers, banning branded drug makers from stifling competition by paying off generic makers or limiting their ability to withhold drug samples.